The Gómez Ulla Military Hospital, presently know officially as Hospital Central de la Defensa Gómez Ulla, is a military hospital in Madrid, located in the Aluche area in the former Carabanchel quarter of the city. It is part of the Spanish Ministry of Defence.

There are 520 beds in Hospital Central de la Defensa Gómez Ulla.

During the past decade, Hospital Central de la Defensa Gómez Ulla conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Central de la Defensa Gómez Ulla" #1 sponsor was "PETHEMA Foundation" with 3 trials, followed by "Fundación EPIC" with 2 trials sponsored, "Fundación Sociedad Española de Oncologia Médica" with 2 trials sponsored, "Hospital Central de la Defensa Gómez Ulla" with 2 trials sponsored and "Abbott Nutrition" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Central de la Defensa Gómez Ulla" #1 collaborator was "Fundación ADEY" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Central de la Defensa Gómez Ulla" are "Multiple Myeloma" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Promyelocytic Leukemia" (1 trials), "Anesthesia" (1 trials) and "Arterial Occlusive Diseases" (1 trials). Many other conditions were trialed in "Hospital Central de la Defensa Gómez Ulla" in a lesser frequency.

Most popular intervention types in "Hospital Central de la Defensa Gómez Ulla" are "Drug" (7 trials), "Other" (2 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATRA" (1 trials), "Allogenic Transplantation" (1 trials), "Apixaban" (1 trials), "Arsenic Trioxide" (1 trials) and "Autologous Transplantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Central de la Defensa Gómez Ulla" are 14 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Central de la Defensa Gómez Ulla". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hospital Central de la Defensa Gómez Ulla, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Central de la Defensa Gómez Ulla, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".